Ivosidenib and Azacitidine in IDH1-Mutated AML
- PMID: 35767449
- DOI: 10.1056/NEJMc2206489
Ivosidenib and Azacitidine in IDH1-Mutated AML
Comment in
-
Ivosidenib and Azacitidine in IDH1-Mutated AML. Reply.N Engl J Med. 2022 Jun 30;386(26):2536-2537. doi: 10.1056/NEJMc2206489. N Engl J Med. 2022. PMID: 35767450 No abstract available.
Comment on
-
Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia.N Engl J Med. 2022 Apr 21;386(16):1519-1531. doi: 10.1056/NEJMoa2117344. N Engl J Med. 2022. PMID: 35443108 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous